Ekta Gupta1, Neha Ballani2, Manoj Kumar2, Shiv Kumar Sarin2. 1. Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110 070, India. ektagaurisha@gmail.com. 2. Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi, 110 070, India.
Abstract
BACKGROUND: Acute viral hepatitis (AVH) is mostly caused by hepatitis E (HEV) and hepatitis A (HAV) viruses in India. This study was undertaken to find out the incidence of various hepatotropic and non-hepatotropic viruses in AVH and acute-on-chronic liver failure (ACLF) patients. METHODS: Six-hundred and seventy-three adult patients of AVH and ACLF were screened for acute serological markers of hepatotropic (A, B, C, D, and E) and the non-hepatotropic cytomegalovirus (CMV) and Epstein-Barr virus (EBV). RESULTS: Viral etiology profile in 295 samples with confirmed etiology were HEV in 155 (52.5 %); HAV in 43 (14.5 %); HBV in 35 (11.8 %); HCV in 1 (0.3 %); mixed viral etiology in 30 (10.1 %); and non-hepatotropic viruses, cytomegalovirus, and Epstein-Barr virus in 31 (10.5 %). Two-hundred and six patients (69.8 %) were AVH and 89 (30.1 %) ACLF. HEV was the commonest cause of infection in both the groups AVH (n = 95, 46.1 %) and ACLF (n = 60, 67.4 %). Twenty-nine (9.8 %) patients died on follow up; mortality was higher in ACLF (25/89, 28 %) than AVH group (4/206, 1.94 %; p < 0.001). The mortality was higher when HEV was the cause of acute event (20/29, 68.9 %). In AVH, mixed infection was more common as compared to ACLF (27 vs. 3, p < 0.001). Non-hepatotropic viruses contributed significantly higher infections in AVH as compared to ACLF (29 vs. 2, p = 0.002) patients. CONCLUSIONS: HEV was an important cause of symptomatic hepatitis in both AVH and ACLF patients. Non-hepatotropic viruses like CMV and EBV were identified in a significant number of patients with AVH and much less frequently in ACLF.
BACKGROUND: Acute viral hepatitis (AVH) is mostly caused by hepatitis E (HEV) and hepatitis A (HAV) viruses in India. This study was undertaken to find out the incidence of various hepatotropic and non-hepatotropic viruses in AVH and acute-on-chronic liver failure (ACLF) patients. METHODS: Six-hundred and seventy-three adult patients of AVH and ACLF were screened for acute serological markers of hepatotropic (A, B, C, D, and E) and the non-hepatotropic cytomegalovirus (CMV) and Epstein-Barr virus (EBV). RESULTS: Viral etiology profile in 295 samples with confirmed etiology were HEV in 155 (52.5 %); HAV in 43 (14.5 %); HBV in 35 (11.8 %); HCV in 1 (0.3 %); mixed viral etiology in 30 (10.1 %); and non-hepatotropic viruses, cytomegalovirus, and Epstein-Barr virus in 31 (10.5 %). Two-hundred and six patients (69.8 %) were AVH and 89 (30.1 %) ACLF. HEV was the commonest cause of infection in both the groups AVH (n = 95, 46.1 %) and ACLF (n = 60, 67.4 %). Twenty-nine (9.8 %) patients died on follow up; mortality was higher in ACLF (25/89, 28 %) than AVH group (4/206, 1.94 %; p < 0.001). The mortality was higher when HEV was the cause of acute event (20/29, 68.9 %). In AVH, mixed infection was more common as compared to ACLF (27 vs. 3, p < 0.001). Non-hepatotropic viruses contributed significantly higher infections in AVH as compared to ACLF (29 vs. 2, p = 0.002) patients. CONCLUSIONS: HEV was an important cause of symptomatic hepatitis in both AVH and ACLF patients. Non-hepatotropic viruses like CMV and EBV were identified in a significant number of patients with AVH and much less frequently in ACLF.
Authors: P Jain; S Prakash; S Gupta; K P Singh; S Shrivastava; D D Singh; J Singh; A Jain Journal: Indian J Med Microbiol Date: 2013 Jul-Sep Impact factor: 0.985
Authors: Mario Fernández-Ruiz; Carolina Muñoz-Codoceo; Francisco López-Medrano; Regina Faré-García; Amparo Carbonell-Porras; Cristina Garfia-Castillo; Raquel Muñoz-Gómez; Jose María Aguado-García Journal: Intern Med Date: 2008-11-17 Impact factor: 1.271
Authors: Miriam Bittel; Andreas E Kremer; Michael Stürzl; Stefan Wirtz; Iris Stolzer; Markus F Neurath; Gianna Ballon; Claudia Günther Journal: Cell Death Dis Date: 2019-11-21 Impact factor: 8.469
Authors: Kirill I Yurlov; Olga V Masalova; Lidiia B Kisteneva; Irina N Khlopova; Evgeny I Samokhvalov; Valentina V Malinovskaya; Vladimir V Parfyonov; Alexander N Shuvalov; Alla A Kushch Journal: Biology (Basel) Date: 2021-05-29